Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
KEGG   DRUG: Pirtobrutinib
Entry
D12050                      Drug                                   
Name
Pirtobrutinib (JAN/USAN);
Jaypirca (TN)
Product
Formula
C22H21F4N5O3
Exact mass
479.1581
Mol weight
479.43
Structure
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG02022  BTK inhibitor
Metabolizing enzyme substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Metabolizing enzyme inhibitor
 DG01641  CYP2C8 inhibitor
 DG01933  CYP2C19 inhibitor
 DG02852  CYP3A/CYP3A4 inhibitor
Transporter inhibitor
 DG01622  ABCB1 inhibitor
 DG02862  ABCG2 inhibitor
Remark
Therapeutic category: 4291
ATC code: L01EL05
Product: D12050<US>
Efficacy
Antineoplastic, Bruton's tyrosine kinase inhibitor
  Disease
Mantle cell lymphoma [DS:H01464]
Target
BTK [HSA:695] [KO:K07370]
  Pathway
hsa04611  Platelet activation
hsa04662  B cell receptor signaling pathway
Metabolism
Enzyme: CYP3A4 [HSA:1576]
Interaction
CYP inhibition: CYP2C8 [HSA:1558], CYP2C19 [HSA:1557], CYP3A [HSA:1576 1577 1551]
Transporter inhibition: ABCB1 [HSA:5243], ABCG2 [HSA:9429]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01E PROTEIN KINASE INHIBITORS
    L01EL Bruton's tyrosine kinase (BTK) inhibitors
     L01EL05 Pirtobrutinib
      D12050  Pirtobrutinib (JAN/USAN) <US>
USP drug classification [BR:br08302]
 Antineoplastics
  Molecular Target Inhibitors
   Pirtobrutinib
    D12050  Pirtobrutinib (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4291  Other Antitumors
     D12050  Pirtobrutinib (JAN/USAN)
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG02022  BTK inhibitor
    D12050  Pirtobrutinib
 Metabolizing enzyme substrate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D12050  Pirtobrutinib
 Metabolizing enzyme inhibitor
  DG01641  CYP2C8 inhibitor
   D12050  Pirtobrutinib
  DG01933  CYP2C19 inhibitor
   D12050  Pirtobrutinib
  DG02852  CYP3A/CYP3A4 inhibitor
   D12050  Pirtobrutinib
 Transporter inhibitor
  DG01622  ABCB1 inhibitor
   D12050  Pirtobrutinib
  DG02862  ABCG2 inhibitor
   D12050  Pirtobrutinib
Drug classes [BR:br08332]
 Antineoplastic
  DG02022  BTK inhibitor
   D12050  Pirtobrutinib
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Non-receptor tyrosine kinases
   TEC family
    BTK
     D12050  Pirtobrutinib (JAN/USAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12050
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D12050
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12050
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12050
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D12050
 Drug transporters
  D12050
Other DBs
CAS: 2101700-15-4
ChEBI: 229212
LinkDB
KCF data

ATOM        34
            1   C8y C    25.8974  -13.9283
            2   C8x C    25.8974  -15.3282
            3   C8x C    24.7075  -16.0281
            4   C8y C    23.4477  -15.3282
            5   C8y C    23.4477  -13.9283
            6   C8x C    24.7075  -13.2284
            7   X   F    27.0873  -13.2284
            8   O2a O    22.2578  -16.0281
            9   C1a C    22.2578  -17.4280
            10  C5a C    22.2578  -13.2284
            11  N1b N    21.0679  -13.9283
            12  O5a O    22.2578  -11.8285
            13  C1b C    19.8780  -13.2284
            14  C8y C    18.6881  -13.9283
            15  C8x C    18.6881  -15.3282
            16  C8x C    17.4282  -16.0281
            17  C8y C    16.2384  -15.3282
            18  C8x C    16.2384  -13.9283
            19  C8x C    17.4282  -13.2284
            20  C8y C    15.0485  -16.0281
            21  N5x N    14.9085  -17.4280
            22  N4y N    13.5086  -17.7079
            23  C8y C    12.8087  -16.5181
            24  C8y C    13.7186  -15.4682
            25  C5a C    13.4386  -14.0683
            26  N1a N    12.1088  -13.6483
            27  O5a O    14.4885  -13.1584
            28  N1a N    11.4088  -16.3781
            29  C1c C    12.9487  -18.9678
            30  C1d C    11.5488  -19.1078
            31  C1a C    13.7886  -20.0877
            32  X   F    10.1490  -19.1078
            33  X   F    11.5488  -20.5077
            34  X   F    11.5488  -17.7079
BOND        36
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     4   8 1
            9     8   9 1
            10    5  10 1
            11   10  11 1
            12   10  12 2
            13   11  13 1
            14   13  14 1
            15   14  15 2
            16   15  16 1
            17   16  17 2
            18   17  18 1
            19   18  19 2
            20   14  19 1
            21   17  20 1
            22   20  21 2
            23   21  22 1
            24   22  23 1
            25   23  24 2
            26   20  24 1
            27   24  25 1
            28   25  26 1
            29   25  27 2
            30   23  28 1
            31   22  29 1
            32   29  30 1
            33   29  31 1
            34   30  32 1
            35   30  33 1
            36   30  34 1

» Japanese version   » Back

DBGET integrated database retrieval system